Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Cipla

Cipla

BSE: 500087|NSE: CIPLA|ISIN: INE059A01026|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Oct 23, 11:48
597.85
-10.35 (-1.7%)
VOLUME 45,977
LIVE
NSE
Oct 23, 11:47
597.30
-10.5 (-1.73%)
VOLUME 570,814
News on Cipla
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Buy Aurobindo Pharma, BPCL: Mitessh Thakkar 

3.40 pm | 17 Oct 2017 |  Source: CNBC-TV18

Mitessh Thakkar of miteshthacker.com recommends buying Aurobindo Pharma and BPCL....

Buy Cipla, Sun Pharm, M&M Financial Services, Tata Chemicals, Vedanta: VK Sharma 

10.33 am | 17 Oct 2017 |  Source: CNBC-TV18

VK Sharma, Head - PCG and Capital Market Strategy at HDFC Securities recommends buying Cipla, Sun Pharmaceutical Industries, Mahindra & Mahindra Finan...

Cipla Q2 PAT seen up 13% YoY to Rs. 406 cr: Kotak

5.43 pm | 13 Oct 2017 |  Source: Moneycontrol.com

Net Sales are expected to increase by 6.7 percent Y-o-Y (up 13.5 percent Q-o-Q) to Rs. 4001 crore, according to Kotak....

Buy Cipla, sell DLF; hold Piramal Enterprises, CRISIL: Sandeep Wagle 

12.02 pm | 22 Sep 2017 |  Source: CNBC-TV18

Sandeep Wagle of powermywealth.com is of the view that one can buy Cipla and sell DLF while can hold Piramal Enterprises and CRISIL....

Buy Cipla, sell Reliance Capital: Rajat Bose 

2.42 pm | 21 Sep 2017 |  Source: CNBC-TV18

Rajat Bose of rajatkbose.com is of the view that one can buy Cipla and sell Reliance Capital....

Positive sentiment for pharma stocks lifts Cipla 4%; UBS maintains buy

1.46 pm | 21 Sep 2017 |  Source: Moneycontrol.com

"Cipla is our top pick in the sector given high branded generic exposure," UBS said....

Buy Cipla, Coal India: Mitessh Thakkar 

3.16 pm | 18 Sep 2017 |  Source: CNBC-TV18

Mitessh Thakkar of miteshthacker.com suggests buying Cipla and Coal India....

New draft pharma policy will reduce risks like generalisation of mkt: JM Financial 

4.04 pm | 15 Sep 2017 |  Source: CNBC-TV18

In an interview to CNBC-TV18, Anmol Ganjoo, Director of JM Financial Institutional Securities spoke about his latest report on Indian pharmaceutical s...

Buy Cipla, Tata Elxsi, ACC: Rajat Bose 

3.11 pm | 12 Sep 2017 |  Source: CNBC-TV18

Rajat Bose of rajatkbose.com suggests buying Cipla, Tata Elxsi and ACC....

Buy Cipla Limited; target of Rs 653: Khambatta Securities

6.11 pm | 23 Aug 2017 |  Source: Moneycontrol.com

Khambatta Securities is bullish on Cipla Limited has recommended buy rating on the stock with a target price of Rs 653 in its research report dated Au...

Buy Cipla Ltd; target of Rs 627: KRChoksey

3.29 pm | 17 Aug 2017 |  Source: Moneycontrol.com

KRChoksey is bullish on Cipla Ltd has recommended buy rating on the stock with a target price of Rs 627 in its research report dated August 14, 2017....

Targeting 15% growth for FY18, export will pick up sizeably: Omkar Speciality 

1.10 pm | 17 Aug 2017 |  Source: CNBC-TV18

In an interview to CNBC-TV18, Pravin Herlekar, CMD of Omkar Speciality Chemicals discussed the company's Q1 performance....

Hold Cipla; target of Rs 525: ICICI Direct

4.27 pm | 16 Aug 2017 |  Source: Moneycontrol.com

ICICI Direct recommended hold rating on Cipla with a target price of Rs 525 in its research report dated August 14, 2017....

Cipla jumps 6% after management's FY18 outlook; analysts retain hold rating

1.54 pm | 14 Aug 2017 |  Source: Moneycontrol.com

With stock trading at 19x FY19 PE and growth dependent on the challenging US business, Jefferies said it maintained hold rating with increased target ...

Hold Cipla; target of Rs 470: ICICI Direct

4.19 pm | 29 May 2017 |  Source: Moneycontrol.com

ICICI Direct recommended hold rating on Cipla with a target price of Rs 470 in its research report dated May 26, 2017....

Hold Cipla; target of Rs 510: Edelweiss

4.47 pm | 26 May 2017 |  Source: Moneycontrol.com

Edelweiss recommended hold rating on Cipla with a target price of Rs 510 in its research report dated May 25, 2017....

Cipla’s post Q4 net loss of Rs 61.8 cr; depreciation & impairment weigh in on financials 

4.58 pm | 25 May 2017 |  Source: Moneycontrol.com

The consolidated earnings before interest, taxes, depreciation and amortisation (EBITDA) came in at Rs 506.2 crore against Rs 176.1 crore during March...

Cipla Q4: Net profit seen at Rs 346.8 crore, revenues could rise to Rs 3,790 crore: Poll 

5.53 pm | 24 May 2017 |  Source: Moneycontrol.com

Meanwhile, the earnings before interest, taxes, depreciation and amortisation could come in at Rs 675.4 crore, while its operating margin is seen at 1...

1 2
Quick Links for Cipla
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.